Glitaris 7.5 Tablet

By Glitaris

Rx

10 Tablet in a Strip

Composition icon

Composition

Pioglitazone(7.5mg)

Manufacturer - Eris Lifesciences Ltd icon

Manufacturer - Eris Lifesciences Ltd

8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after icon

Expires on or after

August, 2026

About Glitaris 7.5 Tablet

Glitaris 7.5 Tablet is a medication specifically designed to address type 2 diabetes mellitus in adults. This tablet is instrumental in regulating the levels of sugar in the blood of individuals dealing with diabetes. By effectively managing blood sugar, Glitaris 7.5 Tablet plays a crucial role in preventing severe diabetes-related complications such as kidney damage and blindness.

It is important to note that Glitaris 7.5 Tablet can be used either on its own or in combination with other medications. The tablet can be taken with or without food, but it is essential to maintain consistency by taking it at the same time each day to maximize its benefits. The appropriate dosage will be determined by your doctor, and adjustments may be necessary based on your body's response to the medication.

Staying compliant with the prescribed medication regimen is crucial, even if you are feeling well or your blood sugar levels seem under control. Abruptly discontinuing Glitaris 7.5 Tablet without consulting your healthcare provider can lead to a spike in blood sugar levels, elevating the risk of kidney damage, vision problems, nerve issues, and even limb loss. Remember, Glitaris 7.5 Tablet is just one component of a comprehensive treatment plan that should also include a balanced diet, regular physical activity, and weight management as directed by your doctor.

While taking Glitaris 7.5 Tablet, it is important to be aware of potential side effects such as headaches, sinusitis, muscle pain, and pharyngitis. If any of these side effects persist or become bothersome, it is advisable to seek guidance from your healthcare provider. Additionally, certain health conditions such as type 1 diabetes mellitus, diabetic ketoacidosis, severe kidney or liver disease, or specific cardiovascular, hormonal, or thyroid disorders may contraindicate the use of Glitaris 7.5 Tablet. Pregnant or breastfeeding individuals should consult their doctor before starting this medication.

In summary, Glitaris 7.5 Tablet, containing Pioglitazone as its active ingredient, belongs to the class of thiazolidinedione (TZD) antidiabetic medications. Its primary function is to enhance the body's utilization of insulin, thus effectively managing blood sugar levels in individuals with type 2 diabetes. Remember to follow your doctor's guidance diligently, maintain healthy lifestyle practices, and attend regular check-ups to monitor your progress while using Glitaris 7.5 Tablet.


Benefits

Glitaris 7.5 Tablet offers a range of benefits, especially for individuals dealing with Type 2 diabetes mellitus. This medication plays a crucial role in improving the body’s response to insulin, a hormone essential for regulating blood glucose levels. By aiding in the effective utilization of insulin, Glitaris 7.5 Tablet assists in lowering blood glucose levels and helps prevent spikes in sugar levels after meals. It is vital to adhere to the prescribed dosage consistently to reap the full benefits of this medication.


Managing blood glucose levels is a key aspect of diabetes care, and Glitaris 7.5 Tablet can significantly contribute to this process. By controlling blood sugar levels, individuals can reduce the risk of developing severe complications associated with diabetes, such as kidney damage, eye problems, nerve issues, and even the potential loss of limbs. Incorporating Glitaris 7.5 Tablet into your daily routine, along with a balanced diet and regular exercise, can lead to a healthier and more normal lifestyle.


Glitaris 7.5 Tablet Tablet 10's, classified as a thiazolidinedione/glitazone antidiabetic drug, is specifically designed to work in conjunction with proper diet and exercise to manage high blood sugar levels in patients with Type 2 diabetes. By aiding the body in restoring its natural response to insulin, this medication effectively lowers blood sugar levels, promoting better overall health. Consistent use of Glitaris 7.5 Tablet Tablet 10's, combined with a healthy lifestyle, can pave the way for a more balanced and fulfilling life for individuals dealing with diabetes.


How to use the Glitaris 7.5 Tablet

To use Glitaris 7.5 Tablet, follow the guidelines provided by your doctor. Swallow the tablet whole with water, without chewing, crushing, or breaking it. You can take this medication with or without food, but it's recommended to take it at the same time every day for better results. Remember to take the medicine exactly as prescribed by your healthcare provider in terms of dosage and duration. If you have any doubts or concerns about how to use Glitaris 7.5 Tablet, consult with your doctor or pharmacist for clarification.


Uses of Glitaris 7.5 Tablet

Glitaris 7.5 Tablet is primarily used in the treatment of Type 2 diabetes mellitus. This medication is specifically intended for individuals with this specific type of diabetes. It helps in managing and controlling blood sugar levels in patients diagnosed with Type 2 diabetes mellitus. By utilizing Glitaris 7.5 Tablet as prescribed, individuals with Type 2 diabetes mellitus can effectively regulate their condition, leading to better health outcomes.


What conditions Glitaris 7.5 Tablet treats?

Glitaris 7.5 Tablet is commonly used for the treatment of type 2 diabetes. This condition is a long-lasting disease that affects how the body uses insulin. Individuals with type 2 diabetes may not make enough insulin or have trouble using it effectively. Typically seen in middle-aged and older adults, symptoms can include increased thirst, frequent night urination, slow wound healing, increased hunger, fatigue, and vision problems. In some cases, weight changes may occur. Complications of type 2 diabetes can involve nerve issues, kidney problems, eye damage, limb loss, sexual dysfunction, and an increased risk of heart attack or stroke.


Should you consult a doctor?

Seek immediate medical attention if you experience symptoms of diabetic ketoacidosis such as high levels of acid in your blood, as Glitaris 7.5 Tablet is not suitable for this condition. Additionally, if you have severe kidney or liver disease, type 1 diabetes mellitus, heart disease, thyroid disease, or hormonal conditions, consult your doctor before starting this medication. Pregnant or breastfeeding women should also seek medical advice before taking Glitaris 7.5 Tablet. Regular monitoring of blood sugar levels, blood cell counts, and liver function is crucial, so consult your doctor for appropriate tests. If you notice persistent or bothersome side effects like headache, sore throat, sinus inflammation, or muscle pain while taking Glitaris 7.5 Tablet, consult your healthcare provider. Remember, this medication is part of a comprehensive treatment plan that includes a healthy diet, regular exercise, and weight management as advised by your doctor.


Side effects of Glitaris 7.5 Tablet

When taking Glitaris 7.5 Tablet, some common side effects may occur as your body gets used to the medication. These side effects are usually mild and temporary. They include headaches, sore throat, sinus inflammation, and muscle pain. However, if these side effects persist or cause concern, it is important to consult your doctor for further advice. In some cases, other side effects such as upper respiratory tract infection, sinusitis, myalgia (muscle pain), and pharyngitis (inflammation of the pharynx) may also occur. It’s always best to seek guidance from your healthcare provider to address any persistent or worrisome side effects.


Safety advice

scroll

liver

When taking Glitaris 7.5 Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment, so consulting your doctor before use is crucial. Avoid using Glitaris 7.5 Tablet if you have severe liver disease to prevent any potential complications. Remember to discuss your liver health history with your healthcare provider before starting this medication.

scroll

kidney

Glitaris 7.5 Tablet is safe for patients with kidney disease. Your doctor may adjust the dose, especially if you have a history of kidney conditions. No dose adjustment of Glitaris 7.5 Tablet is recommended.

scroll

alcohol

For your safety, avoid consuming alcohol with Glitaris 7.5 Tablet to prevent potential side effects.

scroll

driving

Glitaris 7.5 Tablet typically does not impact your driving ability. However, be cautious if you notice any changes in your vision while using Piozar 7.5 Tablet 10's.

scroll

pregnancy

Glitaris 7.5 Tablet is not recommended during pregnancy. Limited human studies and animal research suggest potential harm to the developing baby. Your doctor will evaluate the benefits versus risks before prescribing. Consult your doctor before using Glitaris 7.5 Tablet during pregnancy.

scroll

breastfeeding

During breastfeeding, caution is advised when using Glitaris 7.5 Tablet. It is recommended to wait until the mother's treatment is finished and the drug clears from her body. Monitor the baby's blood sugar while the mother is on Glitaris 7.5 Tablet.


Consumption warning before consuming Glitaris 7.5 Tablet

Before taking Glitaris 7.5 Tablet, please be aware of the following warnings for your safety. The use of Glitaris 7.5 Tablet Tablet 10's may cause fluid retention, which can potentially lead to congestive heart failure. Patients with kidney disease should avoid taking this medication as indicated by a blood test. When using Glitaris 7.5 Tablet Tablet 10's, with or without insulin, it has the potential to lower blood sugar levels, prompting the need for adjustment in insulin dosage by a doctor. Some women taking Glitaris 7.5 Tablet Tablet 10's have reported an increased risk of fractures. If you have bladder cancer or macular oedema (fluid build-up in the macula of the eye), it is advisable to consult your healthcare provider before starting this medication.


Disease interactions

When considering Glitaris 7.5 Tablet, it is vital to note potential interactions with certain medical conditions. Patients with congestive heart failure, type I diabetes, bladder cancer, edema, liver disease, macular edema, premenopausal anovulation, obesity, or anemia should avoid using Glitaris 7.5 Tablet. This medication may exacerbate these conditions. It is recommended that individuals with these health issues consult with their healthcare provider for alternative treatment options to ensure their well-being.


What if you forgot to take Glitaris 7.5 Tablet?

If a dose of Glitaris 7.5 Tablet is missed, it is recommended to skip the missed dose and continue with the regular dosing schedule. It is important not to take a double dose to make up for the missed one. Taking double the dose can lead to an increased risk of side effects and complications. If you have missed a dose, simply wait until the next scheduled dose without doubling up. Maintaining consistency in taking your medication is important for the effectiveness of treatment.


Related lab tests

Related Lab Tests for monitoring the effects of Glitaris 7.5 Tablet include Glucose - Fasting Blood, Glucose - Postprandial Blood, and Glycosylated Hemoglobin tests. These tests help in evaluating the impact of the medication on blood sugar levels. The Glucose - Fasting Blood test measures the amount of sugar in the blood after fasting for a specific period and gives an indication of baseline blood sugar levels. The Glucose - Postprandial Blood test measures blood sugar levels after consuming a meal, providing insights into how the body processes sugars after eating. Lastly, the Glycosylated Hemoglobin test, also known as the HbA1c test, reflects average blood sugar levels over a few months, offering a longer-term assessment of glycemic control. These tests are essential for monitoring the effectiveness of Glitaris 7.5 Tablet in managing blood sugar levels in patients with diabetes.


Additional Information

Habit FormingNo
Chemical ClassThiazolidinedione Derivative
Therapeutic ClassANTI DIABETIC
Action ClassThiazolidinedione(PPAR gamma agonist)

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

62.1

Inclusive of all taxes

Content verified by

chevron-right

Dr. Mansi Chaudhari

MBBS - General Medicine

Last update on 01-Oct-2024